PROTOCOLS & STACKING
How Long Does BPC-157 Take to Work? — Timelines and What Affects Them
By G1 Peptides · Medically reviewed by the G1 Peptides clinical team · Updated October 1, 2026 · 2 min read
THE SHORT ANSWER
Most protocols describe a first response to BPC-157 within one to two weeks, with a typical course lasting four to eight weeks. These timelines come from clinical experience and animal studies, not from controlled human trials, so they are expectations and not guarantees. The type and age of the injury matter more than the dose.
The typical timeline
| When | What protocols describe |
|---|---|
| Days 1 to 7 | Usually nothing noticeable. Injection routine settles in. |
| Weeks 1 to 2 | First reports of reduced pain or stiffness |
| Weeks 2 to 4 | Clearer change in function for many acute injuries |
| Weeks 4 to 8 | End of a typical course, followed by a review |
Treat this as a rough guide. It reflects what providers and patients report and what animal studies show, not the results of a human trial.
Why there is no precise answer
BPC-157 has never been tested in a controlled human trial for tendon, ligament or muscle injury. The timeline in rats is well documented: healing of a cut tendon or ligament is measurably faster within one to two weeks (Chang 2011). Animal healing does not translate directly into human weeks, so any figure for people is an estimate.
What changes the timeline
- The tissue. Muscle has a rich blood supply and heals fastest. Tendon and ligament have a poor supply and heal slowly, with or without a peptide.
- How old the injury is. A recent strain behaves differently from a problem that has been there for a year.
- Whether the cause is still there. An overuse injury keeps being re-injured unless the load changes.
- The rest of the plan. Rehabilitation, sleep and nutrition do most of the work. A peptide is an addition to those, not a replacement.
What "working" should mean
Agree with your provider on what you are measuring before you start: pain on a specific movement, range of motion, or the load you can tolerate. A vague sense of improvement is hard to tell apart from normal healing, which happens on its own in most injuries.
Dose and schedule
Published protocols describe 200 to 500 mcg, once or twice a day, by subcutaneous injection. The half-life is short, which is the reason for daily dosing. The BPC-157 dosage calculator converts a prescribed dose into syringe units.
For the full profile, see What is BPC-157? and BPC-157 explained.
FREQUENTLY ASKED
How quickly does BPC-157 start working?
Protocols commonly describe a first noticeable change within one to two weeks. There is no controlled human trial that measures this, so it is an expectation drawn from clinical experience.
How long should a BPC-157 course last?
Four to eight weeks is the range most often described for an acute injury, with a review at the end. Longer-standing tendon or gut problems are sometimes treated for longer. Your provider sets the duration.
What if nothing has changed after four weeks?
Tell your provider. No change by that point is a reason to reassess the diagnosis and the plan, not a reason to raise the dose on your own.
Does a higher dose work faster?
There is no human evidence that it does. Published protocols stay within 200 to 500 mcg once or twice a day.
SOURCES
- Sikiric P, et al. Stable gastric pentadecapeptide BPC 157 — novel therapy in gastrointestinal tract. Current Pharmaceutical Design (2011)
- Chang CH, et al. The promoting effect of pentadecapeptide BPC 157 on tendon healing involves tendon outgrowth, cell survival, and cell migration. Journal of Applied Physiology (2011)
This article is educational and is not medical advice. Peptides are prescription medications; whether any of them is appropriate for you is a decision for a licensed provider who knows your history.